• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Lilly's Strattera Treats Reading Disorder

Posted on: Friday, 27 October 2006, 12:00 CDT

U.S. firm said Friday its drug Strattera appears effective in treating both attention deficit and reading disorders in children and adolescents.

A recent study by University of Vermont researchers showed that children ages 10 to 16 and adolescents with attention-deficit/hyperactivity disorder and those with a reading disorder similar to dyslexia who took Strattera for 16 weeks had a nearly 50 percent reduction in ADHD symptoms like inattentiveness, hyperactivity and impulsivity.

Also, patients who had both ADHD and the reading disorder saw an average reading composite improvement of approximately two years, compared to 17 months for participants with ADHD alone.

We are encouraged by the results of this study which highlight the importance of considering appropriate treatment options when treating ADHD in patients with ADHD and comorbid conditions, said Richard Rubin, clinical associate professor of psychiatry at the University of Vermont College of Medicine. Since ADHD is often combined with reading disabilities, considering treatment options that are effective in treating ADHD without having an adverse effect on reading performance may provide the best outcome. Strattera is not currently approved to treat reading disorders.

About 15 percent to 30 percent of children with ADHD will also have a reading disorder, Lilly said.

Source: United Press International

More News in this Category